StockData
PERRIGO Co plc logo

PERRIGO Co plc (PRGO) stock

PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3028% below fair value
$16.04−0.90 (-5.31%)

Close on Nov 19, 2026Market cap $2.23BP/E –Yield 7.23%

Perrigo gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Perrigo's gross profit for the twelve months ending Jun 27, 2026 was $1.38B, down 10.8% year over year. For fiscal 2025 it was $1.49B, down 3.1% from the year before. Over ten years it grew 0.3% a year on average. The highest annual figure on record is $1.98B in fiscal 2017.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.49B-3.1%
FY2024Dec 31, 2024$1.54B-8.2%
FY2023Dec 31, 2023$1.68B+15.5%
FY2022Dec 31, 2022$1.46B+2.8%
FY2021Dec 31, 2021$1.42B-5.3%
FY2020Dec 31, 2020$1.49B+4.3%
FY2019Dec 31, 2019$1.43B-21.7%
FY2018Dec 31, 2018$1.83B-7.5%
FY2017Dec 31, 2017$1.98B+20.4%
FY2015Jun 27, 2015$1.64B+13.2%
FY2014Jun 28, 2014$1.45B+13.4%
FY2013Jun 29, 2013$1.28B–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 27, 2026$313.90M-13.5%
Q1 FY2026CQ1 2026Mar 28, 2026$325.50M-17.0%
Q4 FY2025CQ4 2025Dec 31, 2025$362.20M-6.1%
Q3 FY2025CQ3 2025Sep 27, 2025$377.10M-6.8%
Q2 FY2025CQ2 2025Jun 28, 2025$362.90M-8.1%
Q1 FY2025CQ1 2025Mar 29, 2025$392.30M+9.7%
Q4 FY2024CQ4 2024Dec 31, 2024$385.90M-9.7%
Q3 FY2024CQ3 2024Sep 28, 2024$404.40M-1.7%
Q2 FY2024CQ2 2024Jun 29, 2024$394.70M-7.8%
Q1 FY2024CQ1 2024Mar 30, 2024$357.70M-13.6%
Q4 FY2023CQ4 2023Dec 31, 2023$427.30M+11.7%
Q3 FY2023CQ3 2023Sep 30, 2023$411.20M+13.3%
Q2 FY2023CQ2 2023Jul 1, 2023$428.00M+15.0%
Q1 FY2023CQ1 2023Apr 1, 2023$413.80M+22.5%
Q4 FY2022CQ4 2022Dec 31, 2022$382.60M+5.6%
Q3 FY2022CQ3 2022Oct 1, 2022$362.90M+7.9%
Q2 FY2022CQ2 2022Jul 2, 2022$372.10M+6.6%
Q1 FY2022CQ1 2022Apr 2, 2022$337.80M-8.3%
Q4 FY2021CQ4 2021Dec 31, 2021$362.40M-22.8%
Q3 FY2021CQ3 2021Oct 2, 2021$336.40M-9.0%
Q2 FY2021CQ2 2021Jul 3, 2021$349.00M+0.5%
Q1 FY2021CQ1 2021Apr 3, 2021$368.40M-6.4%
Q4 FY2020CQ4 2020Dec 31, 2020$469.20M-2.4%
Q3 FY2020CQ3 2020Sep 26, 2020$369.70M-10.4%
Q2 FY2020CQ2 2020Jun 27, 2020$347.20M-19.4%
Q1 FY2020CQ1 2020Mar 28, 2020$393.70M-12.3%
Q4 FY2019CQ4 2019Dec 31, 2019$480.90M+8.6%
Q3 FY2019CQ3 2019Sep 28, 2019$412.80M-2.8%
Q2 FY2019CQ2 2019Jun 29, 2019$430.80M-8.5%
Q1 FY2019CQ1 2019Mar 30, 2019$448.80M-8.9%
Q4 FY2018CQ4 2018Dec 31, 2018$443.00M-13.6%
Q3 FY2018CQ3 2018Sep 29, 2018$424.80M-14.7%
Q2 FY2018CQ2 2018Jun 30, 2018$471.00M-6.7%
Q1 FY2018CQ1 2018Mar 31, 2018$492.70M+6.1%
Q4 FY2017CQ4 2017Dec 31, 2017$512.70M-14.7%
Q3 FY2017CQ3 2017Sep 30, 2017$497.80M+34.8%
Q2 FY2017CQ2 2017Jul 1, 2017$504.60M–
Q1 FY2017CQ1 2017Apr 1, 2017$464.40M–
Q4 FY2015CQ2 2015Jun 27, 2015$601.00M–
Q3 FY2015CQ1 2015Mar 28, 2015$369.40M–

More Perrigo figures

See a number that looks wrong?